Clinical significance of radiation-induced liver disease after stereotactic body radiation therapy for hepatocellular carcinoma
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: The aim of this study was to investigate parameters that predict radiation-induced liver disease (RILD) following stereotactic body radiotherapy (SBRT) in patients with hepatocellular carcinoma (HCC) and to identify the clinical significance of RILD. Methods: We retrospectively reviewed the medical records of 117 HCC patients who were treated by SBRT from March 2011 to February 2015. RILD was defined as elevated liver transaminases more than five times the upper normal limit or a worsening of Child-Pugh (CP) score by 2 within 3 months after SBRT. All patients were assessed at 1 month and every 3 months after SBRT. Results: Median follow-up was 22.5 months (range, 3 to 56) after SBRT. RILD was developed in 29 of the 117 patients (24.7%). On univariate analysis, significant predictive factors of RILD were pretreatment CP score (p < 0.001) and normal liver volume (p = 0.002). Multivariate analysis showed that CP score was a significant predictor of RILD (p < 0.001). The incidence of RILD increased above a CP score of 6 remarkably. The rate of recovery from RILD decreased significantly above a CP score of 8. Survival analysis showed that CP score was an independent prognostic factor of overall survival (p = 0.001). Conclusions: CP score is a significant factor to predict RILD in patients with chronic liver disease. RILD can be tolerated by patients with a CP score ≤ 7. However, careful monitoring of liver function is needed for patients with a CP score 7 after SBRT.
Abstract
Background/Aims: The aim of this study was to investigate parameters that predict radiation-induced liver disease (RILD) following stereotactic body radiotherapy (SBRT) in patients with hepatocellular carcinoma (HCC) and to identify the clinical significance of RILD. Methods: We retrospectively reviewed the medical records of 117 HCC patients who were treated by SBRT from March 2011 to February 2015. RILD was defined as elevated liver transaminases more than five times the upper normal limit or a worsening of Child-Pugh (CP) score by 2 within 3 months after SBRT. All patients were assessed at 1 month and every 3 months after SBRT. Results: Median follow-up was 22.5 months (range, 3 to 56) after SBRT. RILD was developed in 29 of the 117 patients (24.7%). On univariate analysis, significant predictive factors of RILD were pretreatment CP score (p < 0.001) and normal liver volume (p = 0.002). Multivariate analysis showed that CP score was a significant predictor of RILD (p < 0.001). The incidence of RILD increased above a CP score of 6 remarkably. The rate of recovery from RILD decreased significantly above a CP score of 8. Survival analysis showed that CP score was an independent prognostic factor of overall survival (p = 0.001). Conclusions: CP score is a significant factor to predict RILD in patients with chronic liver disease. RILD can be tolerated by patients with a CP score ≤ 7. However, careful monitoring of liver function is needed for patients with a CP score 7 after SBRT.
참고문헌 (29)
- Ferlay J, "Estimates of worldwide burden of cancer in 2008:GLOBOCAN 2008", Int J Cancer, 127, pp.2893~2917 (2010)
- Ikai I, "Report of the 18th follow-up survey of primary liver cancer in Japan", Hepatol Res, 40, pp.1043~1059 (2010)
- Sheu JC, "Small hepatocellular carcinoma: intratumor ethanol treatment using new needle and guidance systems", Radiology, 163, pp.43~48 (1987)
- Ikeda K, "Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma:an analysis by the Cox proportional hazard model", Cancer, 68, pp.2150~2154 (1991)
- Lawrence TS, "Hepatic toxicity resulting from cancer treatment", Int J Radiat Oncol Biol Phys, 31, pp.1237~1248 (1995)
- Dawson LA, "Analysis of radiation-induced liver disease using the Lyman NTCP model", Int J Radiat Oncol Biol Phys, 53, pp.810~821 (2002)
- Liang SX, "Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance", Int J Radiat Oncol Biol Phys, 65, pp.426~434 (2006)
- Yoon SM, "Stereotactic body radiation therapy as an alternative treatment for small hepatocellular carcinoma", PLoS One, 8, pp.e79854~ (2013)
- Jung J, "Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters", Radiat Oncol, 8, pp.249~ (2013)
- Osmundson EC, "Predictors of toxicity associated with stereotactic body radiation therapy to the central hepatobiliary tract", Int J Radiat Oncol Biol Phys, 91, pp.986~994 (2015)
- Sanuki N, "Influence of liver toxicities on prognosis after stereotactic body radiation therapy for hepatocellular carcinoma", Hepatol Res, 45, pp.540~547 (2015)
- Song JH, "Identification of biologically effective dose-volumetric parameters that predict radiation-induced hepatic toxicity in patients treated with helical tomotherapy for unresectable locally advanced hepatocellular carcinoma", Medicine (Baltimore), 94, pp.e1904~ (2015)
- Son SH, "Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: dose-volumetric parameters predicting the hepatic complication", Int J Radiat Oncol Biol Phys, 78, pp.1073~1080 (2010)
- Liang SX, "Dosimetric predictor identification for radiation-induced liver disease after hypofractionated conformal radiotherapy for primary liver carcinoma patients with Child-Pugh Grade A cirrhosis", Radiother Oncol, 98, pp.265~269 (2011)
- Cheng JC, "Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease", Int J Radiat Oncol Biol Phys, 60, pp.1502~1509 (2004)
- Cardenes HR, "Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma", Clin Transl Oncol, 12, pp.218~225 (2010)
- Pan CC, "Radiation-associated liver injury", Int J Radiat Oncol Biol Phys, 76(3Suppl), pp.S94~S100 (2010)
- Liaw YF, "Lamivudine for patients with chronic hepatitis B and advanced liver disease", N Engl J Med, 351, pp.1521~1531 (2004)
- Guha C, "Hepatic radiation toxicity: avoidance and amelioration", Semin Radiat Oncol, 21, pp.256~263 (2011)
- Scorsetti M, "The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT)", J Cancer Res Clin Oncol, 141, pp.1301~1309 (2015)
- Mendez Romero A, "Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase I-II study", Acta Oncol, 45, pp.831~837 (2006)
- Okajima C, "Prognostic role of Child-Pugh score 5 and 6 in hepatocellular carcinoma patients who underwent curative hepatic resection", Am J Surg, 209, pp.199~205 (2015)
- Kim HY, "Worse outcome of sorafenib therapy associated with ascites and Child-Pugh score in advanced hepatocellular carcinoma", J Gastroenterol Hepatol, 28, pp.1756~1761 (2013)
- Huertas A, "Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma", Radiother Oncol, 115, pp.211~216 (2015)
- Andolino DL, "Stereotactic body radiotherapy for primary hepatocellular carcinoma", Int J Radiat Oncol Biol Phys, 81, pp.e447~e453 (2011)
- Tse RV, "Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma", J Clin Oncol, 26, pp.657~664 (2008)
- Kim TH, "Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.", Int J Radiat Oncol Biol Phys, 67, pp.225~231 (2007)
- Son SH, "Significance of an increase in the Child-Pugh score after radiotherapy in patients with unresectable hepatocellular carcinoma", Radiat Oncol, 9, pp.101~ (2014)
- Culleton S, "Outcomes following definitive stereotactic body radiotherapy for patients with Child-Pugh B or C hepatocellular carcinoma", Radiother Oncol, 111, pp.412~417 (2014)